share_log

Deutsche Bank Initiates Coverage On Neumora Therapeutics With Hold Rating, Announces Price Target of $13

Benzinga ·  Dec 12, 2023 05:06

Deutsche Bank analyst Neena Bitritto-Garg initiates coverage on Neumora Therapeutics (NASDAQ:NMRA) with a Hold rating and announces Price Target of $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment